A detailed history of Patton Fund Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Patton Fund Management, Inc. holds 28,466 shares of ABBV stock, worth $5.23 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
28,466
Holding current value
$5.23 Million
% of portfolio
1.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 22, 2025

BUY
$164.99 - $203.87 $4.7 Million - $5.8 Million
28,466 New
28,466 $5.06 Million
Q1 2023

Apr 06, 2023

SELL
$144.61 - $166.54 $728,111 - $838,528
-5,035 Reduced 35.04%
9,335 $1.49 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $6,915 - $8,293
50 Added 0.35%
14,370 $2.32 Million
Q3 2022

Oct 21, 2022

SELL
$134.21 - $153.93 $170,446 - $195,491
-1,270 Reduced 8.15%
14,320 $1.92 Million
Q2 2022

Jul 22, 2022

BUY
$137.62 - $174.96 $2.15 Million - $2.73 Million
15,590 New
15,590 $2.39 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $325B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Patton Fund Management, Inc. Portfolio

Follow Patton Fund Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Patton Fund Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Patton Fund Management, Inc. with notifications on news.